GTBP

GT BIOPHARMA INC

GTBP·36254L308·US·Common Stock·Healthcare - Biotechnology-13D/G

GTBP (GT BIOPHARMA INC) is held by 19 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($184,365), GEODE CAPITAL MANAGEMENT, LLC ($120,170), VANGUARD FIDUCIARY TRUST CO ($92,183). Net institutional sentiment: Mixed.

19
Holders
(1 Elite)
$500,018
Total Value
58% (19)
Consensus
11 buying - 8 selling
13F: Insider & Congress:
GTBPSmart Money Verdict
View all
Held by 19 funds
1 elite
Who's Trading
ActivistBIBristol Investment Fund, Ltd.2.4%Jun 2, 2025
ActivistFNFive Narrow Lane LP10.0%May 14, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
451,875$184,3650.0%-8.51%
35
Increased
294,459(+1429.0%)$120,1700.0%-94.21%
24
New
225,938$92,1830.0%-8.51%
33
Decreased
66,165(-18.1%)$27,0020.0%-38.32%
0
Increased
45,970(+46.0Kx)$18,7560.0%-8.53%
20
Increased
30,382(+185.8%)$12,3990.0%-26.99%
19
Increased
21,000(+950.0%)$8,5720.0%-44.68%
18
Increased
20,023(+33.5%)$8,1710.0%-40.67%
14
Unchanged
20,006$8,1640.0%-46.91%
0
Decreased
16,599(-10.8%)$6,7740.0%-63.54%
0
Unchanged
16,037$6,5450.0%-91.08%
0
Decreased
8,408(-0.0%)$3,4310.0%-85.90%
0
Increased
4,501(+4500x)$1,8370.0%-8.63%
12
Unchanged
3,000$1,2280.0%-46.91%
0
New
1,000$4080.0%-8.51%
17
Unchanged
16$70.0%-88.90%
0
New
14,876$60.0%-8.51%
15
Exited
0(-100.0%)$2,1840.0%-41.98%
0
New
126$00.0%-8.51%
17
Exited
0(-100.0%)$190.0%-84.76%
0

Showing 1-20 of 24

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used